Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly

Despite advances in medical care, cancer remains a major threat to human health. Antibody-drug conjugates (ADCs) are a promising targeted therapy to overcome adverse side effects to normal tissues. In this field, the current challenge is obtaining homogeneous preparations of conjugates, where a defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Farràs, Mercè, Miret, Joan, Camps, Marc, Román, Ramón, Martínez, Óscar, Pujol, Xavier, Erb, Stéphane, Ehkirch, Anthony, Cianferani, Sarah, Casablancas, Antoni, Cairó, Jordi Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973308/
https://www.ncbi.nlm.nih.gov/pubmed/31876436
http://dx.doi.org/10.1080/19420862.2019.1702262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973308/
https://www.ncbi.nlm.nih.gov/pubmed/31876436
http://dx.doi.org/10.1080/19420862.2019.1702262

Ejemplares similares